Imaflex Dirección

Dirección controles de criterios 4/4

El CEO de Imaflex's es Joe Abbandonato , nombrado en Jun 2023, tiene una permanencia de menos de un año. compensación anual total es CA$169.32K, compuesta por 93.5% salario y 6.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 27.78% de las acciones de la empresa, por valor de CA$11.43M. La antigüedad media del equipo directivo y de la junta directiva es de 9.2 años y 10 años, respectivamente.

Información clave

Joe Abbandonato

Chief Executive Officer (CEO)

CA$154.9k

Compensación total

Porcentaje del salario del CEO	92.8%
Permanencia del CEO	less than a year
Participación del CEO	27.8%
Permanencia media de la dirección	6yrs
Promedio de permanencia en la Junta Directiva	12.3yrs

Actualizaciones recientes de la dirección

Recent updates

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Jun 10

Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Jun 03

Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Apr 19

Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Mar 30

Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Mar 01

Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 04

Is Imaflex (CVE:IFX) A Risky Investment?

Jan 17

What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Dec 30

Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Dec 15

Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

Nov 30

What Does Imaflex's (CVE:IFX) CEO Pay Reveal?

Nov 26

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Joe Abbandonato en comparación con los beneficios de Imaflex?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	CA$1m
Dec 31 2023	CA$155k	CA$144k	CA$509k
Sep 30 2023	n/a	n/a	CA$2m
Jun 30 2023	n/a	n/a	CA$5m
Mar 31 2023	n/a	n/a	CA$8m
Dec 31 2022	CA$169k	CA$158k	CA$9m
Sep 30 2022	n/a	n/a	CA$10m
Jun 30 2022	n/a	n/a	CA$10m
Mar 31 2022	n/a	n/a	CA$8m
Dec 31 2021	CA$166k	CA$158k	CA$8m
Sep 30 2021	n/a	n/a	CA$8m
Jun 30 2021	n/a	n/a	CA$7m
Mar 31 2021	n/a	n/a	CA$5m
Dec 31 2020	CA$166k	CA$158k	CA$6m
Sep 30 2020	n/a	n/a	CA$5m
Jun 30 2020	n/a	n/a	CA$4m
Mar 31 2020	n/a	n/a	CA$4m
Dec 31 2019	CA$166k	CA$158k	CA$2m
Sep 30 2019	n/a	n/a	CA$2m
Jun 30 2019	n/a	n/a	CA$2m
Mar 31 2019	n/a	n/a	CA$2m
Dec 31 2018	CA$170k	CA$158k	CA$4m
Sep 30 2018	n/a	n/a	CA$4m
Jun 30 2018	n/a	n/a	CA$4m
Mar 31 2018	n/a	n/a	CA$4m
Dec 31 2017	CA$165k	CA$158k	CA$4m

Compensación vs. Mercado: La compensación total de Joe($USD112.76K) está por debajo de la media de empresas de tamaño similar en el mercado Canadian ($USD175.97K).

Compensación vs. Ingresos: La compensación de Joe ha sido consistente con los resultados de la empresa en el último año.

CEO

Joe Abbandonato

less than a year

Permanencia

CA$154,914

Compensación

Mr. Joseph Marino Abbandonato, also known as Joe, had been the Chief Executive Officer and President at Imaflex Inc., since 1993 until May 2023 and serves as its Executive Chairman since May 2023 and serve...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Joseph Abbandonato	Chairman of the Board of Directors	less than a year	CA$154.91k	27.78% CA$ 16.2m
Robert Therrien	Director of Finance	less than a year	CA$33.85k	sin datos
Tony Abbandonato	VP of Sales	31.4yrs	CA$205.28k	3.9% CA$ 2.3m
Ralf Dujardin	Vice President of Marketing & Innovation	10.9yrs	CA$230.19k	sin datos

6.0yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de IFX es experimentado (9.2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Joseph Abbandonato	Chairman of the Board of Directors	25.7yrs	CA$154.91k	27.78% CA$ 16.2m
Tony Abbandonato	VP of Sales	8yrs	CA$205.28k	3.9% CA$ 2.3m
Michel Baril	Independent Director	16.3yrs	CA$8.00k	0.13% CA$ 78.4k
Roberto Longo	Independent Director	2.2yrs	CA$9.00k	0.0096% CA$ 5.6k
Philip Nolan	Independent Director	23yrs	CA$8.00k	9.29% CA$ 5.4m
Consolato Gattuso	Independent Director	12.3yrs	CA$8.00k	0.18% CA$ 106.8k
Lorne Steinberg	Independent Director	7yrs	CA$8.00k	0.19% CA$ 112.0k

12.3yrs

Permanencia media

Junta con experiencia: Los miembros de la junta directiva de IFX son experimentados ( 12.3 años antigüedad media).

Imaflex Dirección

Dirección controles de criterios 4/4

Información clave

Actualizaciones recientes de la dirección

Insufficient new directors

Imaflex Inc., Annual General Meeting, Jun 13, 2024

Insider recently sold CA$67k worth of stock

Imaflex Inc. Announces CEO Changes

Imaflex Inc. Appoints Roger Tambay as CEO

Imaflex Inc. Announces Chief Financial Officer Changes

Recent updates

Revenues Not Telling The Story For Imaflex Inc. (CVE:IFX) After Shares Rise 48%

Investor sentiment improves as stock rises 18%

There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

First quarter 2024 earnings released: EPS: CA$0.04 (vs CA$0.018 in 1Q 2023)

Insufficient new directors

Full year 2023 earnings released: EPS: CA$0.01 (vs CA$0.18 in FY 2022)

Imaflex Inc., Annual General Meeting, Jun 13, 2024

Imaflex (CVE:IFX) Might Be Having Difficulty Using Its Capital Effectively

Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.06 in 3Q 2022)

Is Imaflex (CVE:IFX) A Risky Investment?

Second quarter 2023 earnings released: EPS: CA$0.01 (vs CA$0.066 in 2Q 2022)

Investor sentiment deteriorates as stock falls 18%

Insider recently sold CA$67k worth of stock

Imaflex Inc. Announces CEO Changes

Imaflex Inc. Appoints Roger Tambay as CEO

First quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.04 in 1Q 2022)

Imaflex Inc. Announces Chief Financial Officer Changes

Does Imaflex (CVE:IFX) Deserve A Spot On Your Watchlist?

Full year 2022 earnings released: EPS: CA$0.18 (vs CA$0.17 in FY 2021)

We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Third quarter 2022 earnings released: EPS: CA$0.06 (vs CA$0.055 in 3Q 2021)

Imaflex Inc. Provides Earnings Guidance for the Full Year 2022

Price target increased to CA$1.95

Insufficient new directors

Imaflex Inc. Submits Advaseal® Registration Package to the EPA

Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Second quarter 2022 earnings released: EPS: CA$0.07 (vs CA$0.04 in 2Q 2021)

VP of Manufacturing recently sold CA$56k worth of stock

First quarter 2022 earnings released: EPS: CA$0.04 (vs CA$0.039 in 1Q 2021)

Is It Too Late To Consider Buying Imaflex Inc. (CVE:IFX)?

Price target increased to CA$1.95

Insufficient new directors

Imaflex Inc. Provides Earnings Guidance for the First Quarter 2022

Full year 2021 earnings released: EPS: CA$0.17 (vs CA$0.13 in FY 2020)

Imaflex Inc., Annual General Meeting, Jun 16, 2022

Imaflex Inc. Appoints Roberto Longo as Director, Chair the Audit Committee

Imaflex Inc. Announces Resignation of Mario Settino as Director

Vice-President of Corporate Affairs recently sold CA$56k worth of stock

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

Imaflex (CVE:IFX) Could Easily Take On More Debt

Insider recently sold CA$520k worth of stock

VP of Manufacturing recently sold CA$98k worth of stock

Insider exercised options to buy CA$540k worth of stock.

Investors Should Be Encouraged By Imaflex's (CVE:IFX) Returns On Capital

Vice-President of Corporate Affairs exercised options to buy CA$735k worth of stock.

Second quarter 2021 earnings released: EPS CA$0.04 (vs CA$0.007 in 2Q 2020)

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

First quarter 2021 earnings released: EPS CA$0.039 (vs CA$0.062 in 1Q 2020)

Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Full year 2020 earnings released: EPS CA$0.13 (vs CA$0.031 in FY 2019)

Investor sentiment improved over the past week

Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Imaflex Announces Positive Independent Results for the ADVASEAL Release Study

New 90-day high: CA$1.22

Is Imaflex (CVE:IFX) A Risky Investment?

What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

Insider recently sold CA$108k worth of stock

Revenue beats expectations

Imaflex Inc. Updates on Its ADVASEAL Study

What Does Imaflex's (CVE:IFX) CEO Pay Reveal?

New 90-day high: CA$0.78

New 90-day high: CA$0.77

Price target lowered to CA$0.90

First half earnings released